02/28/2026
Today is Rare Disease Day — and Tralyte Health is now live on Wefunder, an equity crowdfunding platform that allows individuals to invest in early-stage companies.
For people living with hypoparathyroidism and other rare conditions, “awareness” isn’t abstract — it’s daily reality. It’s uncertainty. It’s lab visits. It’s weekend decisions about whether symptoms are serious enough for the emergency department.
Rare Disease Day is about recognizing that reality and advancing solutions.
Today is Rare Disease Day — and Tralyte Health is now live on Wefunder, an equity crowdfunding platform that allows individuals to invest in early-stage companies.
For people living with hypoparathyroidism and other rare conditions, “awareness” isn’t abstract — it’s daily reality. It’s uncertainty. It’s lab visits. It’s weekend decisions about whether symptoms are serious enough for the emergency department.
Rare Disease Day is about recognizing that reality — and advancing solutions.
This week, we launched our Wefunder campaign to support development of our first alpha prototype for a home calcium monitor. Community investment will help accelerate this work and bring better tools to patients living with hypopara and other conditions involving calcium imbalance.
We have received — and are grateful for — early-stage support from Activation Capital, Virginia IPC, and Virginia Commonwealth University.
Innovation in rare disease requires persistence and community momentum. Today, we recognize the rare community and take a concrete step from awareness to action.
https://wefunder.com/tralyte.health.inc
Invest as little as $100 in startups and small businesses. Wefunder is the largest Regulation Crowdfunding portal.
